News

Human in Motion Robotics Shines at CES 2025 with XoMotion™

Human in Motion Robotics Shines at CES 2025 with XoMotion™

Human in Motion Robotics Shines at CES 2025 with XoMotion™

Human in Motion Robotics, a frontrunner in robotic mobility and humanoid technology, recently celebrated a significant achievement at CES 2025, where their groundbreaking product, XoMotion™, was recognized as the Top Robot by USA Today.

This revolutionary medical exoskeleton has garnered attention for its superb design and outstanding potential to help individuals with mobility impairments overcome challenges associated with spinal cord injuries, strokes, and various neurological conditions.

Highlights from CES 2025

As CES 2025, held in the vibrant city of Las Vegas, came to a close, Human in Motion Robotics reflected on a successful exhibition filled with applause and admiration.

Recognition and Awards

XoMotion not only received positive feedback from visitors and media but also earned the prestigious CES 2025 Innovations Award. This honor reaffirms its position as a leading product exemplifying human-centered technological advancements.

Demonstrations and Engagements

During the event, attendees, including individuals facing mobility challenges, therapists, and healthcare professionals, had the unique opportunity to experience XoMotion firsthand. Its self-balancing features and hands-free motion capabilities showcased how it empowers users, promoting independence while enhancing care practices.

Investor and Partner Interest

The innovative platform and multidisciplinary expertise offered by Human in Motion Robotics struck a chord with potential investors and partners. The versatility of XoMotion positions it not just as a rehabilitation solution but as a broad-spectrum tool in the health technology sphere.

Future Collaborations

Networking with other exhibitors provided valuable insights and inspiration for future projects, emphasizing a collaborative spirit within the technology community at CES.

Meet Chloë Angus

A key highlight during CES 2025 was the chance to meet Chloë Angus, the Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë's remarkable personal journey underscores the potential of XoMotion. After facing her own life-altering medical challenges, she has been pivotal in the product's development, ensuring that it authentically addresses user concerns and needs.

Revolutionizing Rehabilitation Technology

XoMotion represents a major breakthrough in assistive technology, as it aims to redefine patient rehabilitation. Its intuitive design facilitates natural movement, reducing the physical and mental burden on therapists while allowing users to reclaim their independence.

Key Features of XoMotion

  • Self-Balancing: Empowers users with stability and safety through advanced actuators that replicate human walking.
  • Hands-Free Operation: Enhances users' upper body functionality for improved interaction with their environment.
  • Omnidirectional Movement: Facilitates complex walking tasks, ensuring expansive mobility capabilities.
  • Adaptable Applications: Targets a wide range of recovery stages for patients post injury or surgery.
  • Therapist-Optimized: Designed to ease the physical demands on therapists, allowing them to concentrate on patient care.

Availability and Commitment to Progress

Human in Motion Robotics aims to ensure that XoMotion is accessible to those in need. Currently, the exoskeleton can be acquired by rehabilitation facilities in Canada and is available for research purposes globally. The company is diligently working towards obtaining FDA approval in the United States, with plans for expansion into global markets, including Europe and Asia.

For further inquiries or to schedule a demonstration, individuals are encouraged to reach out via their official communications.

About Human in Motion Robotics

Located in Vancouver, Canada, Human in Motion Robotics is on a mission to advance robotic mobility and humanoid technology. With a focus on enhancing patient outcomes and supporting healthcare professionals, the company is dedicated to transforming rehabilitation through innovative technology.

Frequently Asked Questions

What is XoMotion?

XoMotion is a state-of-the-art medical exoskeleton designed to assist individuals with mobility impairments due to various medical conditions.

What recognition did Human in Motion Robotics receive at CES 2025?

XoMotion was named the Top Robot and also won a CES 2025 Innovations Award, highlighting its innovation and impact.

How does XoMotion benefit users with mobility challenges?

The exoskeleton provides hands-free, self-balancing support, enabling users to regain independence and participate in daily tasks.

Who is Chloë Angus?

Chloë Angus is the Product Ambassador for Human in Motion Robotics, contributing her personal experience to shape the development of XoMotion.

Where can XoMotion be accessed?

XoMotion is available to rehabilitation facilities in Canada and for research purposes globally, with plans for broader availability in the future.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 185

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 170

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 234

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 230

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Total Voting Rights: A Crucial Overview

Updated Category News Views 192

Insights into Total Voting Rights and Capital Octopus AIM VCT plc is a company that regularly updates its shareholders regarding vital information, including total voting rights and capital structure. Current Share Capital Details As of the latest disclosure period, Octopus AIM VCT plc has an issued share capital comprising 223,655,160 Ordinary shares, each valued at 1...

Continue Reading
Understanding Market Sentiment for Bio-Techne's Stock

Updated Category News Views 130

Analyzing Bio-Techne's Market Position Bio-Techne (NYSE: TECH) has recently seen an increase in the short percent of float, now standing at 29.12% since its last report. This translates to approximately 5.08 million shares sold short, making up 3.68% of all available regular shares for trading. With the current trading volume, it would typically take about 2.66 days for...

Continue Reading
Innovative Developments in Wound Care by Kane Biotech Inc.

Updated Category News Views 120

Advancements in Wound Care from Kane Biotech Inc. WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is making headlines with groundbreaking clinical and scientific advancements in wound care. The company recently showcased its innovative data during the Innovations in Wound Healing Annual Meeting, an event dedicated to revolutionizing treatment in this critical field....

Continue Reading
Senior Helpers Achieves Recognition as a Leading Franchise

Updated Category News Views 178

Senior Helpers Achieves Recognition as a Leading Franchise Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers' Support and Overall Performance Senior Helpers has recently been awarded the title of a Top Franchise for 2025 by Franchise Business Review (FBR). This year marks a significant milestone as it is FBR's 20th year of recognizing...

Continue Reading
Bearish Moves: What Big Players Think of Super Micro Computer

Updated Category News Views 232

Diving into Super Micro Computer's Options Landscape You gotta love this market, right? Sometimes it’s a real gut check, and right now, Super Micro Computer (NASDAQ:SMCI) is at the forefront of some, let’s say, interesting options activity. Financial giants are making bearish moves—like, big-time bearish. Our look into the options history for good ol' SMCI shook out...

Continue Reading